Ramaswamy Vivek 4
4 · Roivant Sciences Ltd. · Filed Nov 17, 2025
Insider Transaction Report
Form 4
Ramaswamy Vivek
10% Owner
Transactions
- Sale
Common Shares
2025-11-13$20.81/sh−287,283$5,978,359→ 35,221,076 total - Sale
Common Shares
2025-11-14$20.33/sh−1,027,670$20,892,531→ 34,193,406 total - Sale
Common Shares
2025-11-17$20.51/sh−539,650$11,068,222→ 33,653,756 total
Holdings
- 13,357,857(indirect: Spousal)
Common Shares
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.54 to $21.08, inclusive. The reporting person undertakes to provide to Roivant Sciences Ltd., any security holder of Roivant Sciences Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $21.11, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.72, inclusive.
- [F4]Represents the quantity of shares held indirectly only.